the aid library

LIST OPTIONS

Filter

10071

Download (279)

View PDF (310)

Effect of the COVID-19 pandemic response on intrapartum care, stillbirth, and neonatal mortality outcomes in Nepal: a prospective observational study

Ashish KC, R. Gurung, M.V Kinney, et al. (2020) CC

Download (688)

View PDF (1735)

Community health worker programmes after the 2013–2016 Ebola outbreak - Bulletin

Henry B. Perry, Ranu S. Dhillon, Anne Liu, et al. (2016) C_WHO

Download (167)

View PDF (273)

A systematic map and in-depth review of European telehealth interventions efficacy for chronic obstructive pulmonary disease

Gaveikaite, V.; Grunstrom, C.; Winter, S.; et al. Respiratory Medicine (2019) CC2

The article investigates the effectiveness and challenges of remote monitoring systems for chronic respiratory diseases, focusing on COPD and asthma. It reviews various technologies and their potential to improve patient outcomes through better symptom tracking, medication adherence, and early detec... more

Download (232)

View PDF (256)

Kids, Vaayu & Corona: Who wins the fight? - A Comic for COVID-19 Awareness

R. Khaiwal; S. Mor Government of India; Panjab University; Postgraduate Institute of Medical Education and Research Chandigarh; Ministry of Health & Family Welfare; et al. (2020) C2

Accessed: 08.04.2020

Download (316)

View PDF (338)

Zambia Population-based HIV Impact Assessement ZAMPHIA 2016

Ministry of Health, Zambia; Zambia National Public Health Institute; University of Zambia, et al. (2019) CC

External Link

Second nationwide anti-tuberculosis drug resistance survey in Namibia

Ruswa, N.; Mavhunga, F.; J. C. Roscoe; et al. (2019) CC2

Int J Tuberc Lung Dis. 2019 Jul 1;23(7):858–864.Namibia ranks among the 30 high TB burden countries worldwide. Here, we report results of the second nationwide anti-TB drug resistance survey. To assess the prevalence and trends of multidrug-resistant TB (MDR-TB) in Namibia. From 2014 to 2015, pat... more

External Link

Strengthening Kangaroo Mother Care at a tertiary level hospital in Zambia: A prospective descriptive study

Muttau, N.; Mwendafilumba, M; Lewis, B. et al. (2022) CC

PLoS ONE 17(9): e0272444. https://doi.org/ 10.1371/journal.pone.0272444. Based on the RE-AIM metrics, our results show that KMC is a feasible intervention that can improve neonatal outcomes among preterm infants in Zambia. The study findings show a promising, practical approach to scaling up KMC in... more

Download (217)

View PDF (464)

журнал психиатрия 1`2014

Гаврилова С.И, Aлесенко А.В., Mолочкина Е.М. et al. ФГБНУ «Научный центр психического здоровья» (2014) C2

Материалы научно-практической конференции с международным участием «Достижения в нейробиологии и терапии болезни Альцгеймера», посвященной памяти профессора Э.�... more

External Link

Leveraging health infrastructure to optimize HPV vaccination for adolescents in Zambia: Protocol for an implementation study

Miti, S.; Shato, T.; Asante, C. et al. (2023) CC

PLoS ONE 18(5): e0285031. https://doi.org/10.1371/journal.pone.0285031 The study aims to integrate HPV vaccination into routine care in adolescent HIV clinics. To achieve success, we will co-design a package of implementation strategies using a previously successful implementation research approach... more

External Link

Motivation and retention of primary healthcare workers in rural health facilities: An exploratory qualitative study of Chipata and Chadiza Districts, Zambia.

Manda, K.; Silumbwe, A.; Kombe, M.M. et al. ResearchSquare (2022) CC

While motivational factors vary, opportunities for career advancement, stimulating and challenging tasks, opportunities for promotion, and co-worker recognition are core factors that can engender retention of rural health workers. Interventions are required to enhance rural health worker motivation ... more

Download (133)

View PDF (105)

Financing the Pandemic Cycle: Prevention, Preparedness, Response, and Recovery and Reconstruction

Fan V. Y., Kim S., Pineda D., et al. Center for Global Development (2024) CC

The COVID-19 pandemic exposed critical gaps in the global response to health crises, particularly in the financing of pandemic prevention, preparedness, response, recovery, and reconstruction. This chapter presents a comprehensive framework for pandemic financing that spans the entire pandemic cycle... more

External Link

External Link (202)

Estimates of aid for reproductive, maternal, newborn, and child health: findings from application of the Muskoka2 method, 2002–17

Dingle, A.; Schäferhoff, M.; Borghi, J. et al. The Lancet (2020) CC

Background Four methods have previously been used to track aid for reproductive, maternal, newborn, and child health (RMNCH). At a meeting of donors and stakeholders in May, 2018, a single, agreed method was requested to produce accurate, predictable, transparent, and up-to-date estimates that coul...d be used for analyses from both donor and recipient perspectives. Muskoka2 was developed to meet these needs. We describe Muskoka2 and present estimates of levels and trends in aid for RMNCH in 2002–17, with a focus on the latest estimates for 2017. Methods Muskoka2 is an automated algorithm that generates disaggregated estimates of aid for reproductive health, maternal and newborn health, and child health at the global, donor, and recipient-country levels. We applied Muskoka2 to the Organisation for Economic Co-operation and Development's Creditor Reporting System (CRS) aid activities database to generate estimates of RMNCH disbursements in 2002–17. The percentage of disbursements that benefit RMNCH was determined using CRS purpose codes for all donors except Gavi, the Vaccine Alliance; the UN Population Fund; and UNICEF; for which fixed percentages of aid were considered to benefit RMNCH. We analysed funding by donor for the 20 largest donors, by recipient-country income group, and by recipient for the 16 countries with the greatest RMNCH need, defined as the countries with the worst levels in 2015 on each of seven health indicators. Findings After 3 years of stagnation, reported aid for RMNCH reached $15·9 billion in 2017, the highest amount ever reported. Among donors reporting in both 2016 and 2017, aid increased by 10% ($1·4 billion) to $15·4 billion between 2016 and 2017. Child health received almost half of RMNCH disbursements in 2017 (46%, $7·4 billion), followed by reproductive health (34%, $5·4 billion), and maternal and newborn health (19%, $3·1 billion). The USA ($5·8 billion) and the UK ($1·6 billion) were the largest bilateral donors, disbursing 46% of all RMNCH funding in 2017 (including shares of their core contributions to multilaterals). The Global Fund and Gavi were the largest multilateral donors, disbursing $1·7 billion and $1·5 billion, respectively, for RMNCH from their core budgets. The proportion of aid for RMNCH received by low-income countries increased from 31% in 2002 to 52% in 2017. Nigeria received 7% ($1·1 billion) of all aid for RMNCH in 2017, followed by Ethiopia (6%, $876 million), Kenya (5%, $754 million), and Tanzania (5%, $751 million). Interpretation Muskoka2 retains the speed, transparency, and donor buy-in of the G8's previous Muskoka approach and incorporates eight innovations to improve precision. Although aid for RMNCH increased in 2017, low-income and middle-income countries still experience substantial funding gaps and threats to future funding. Maternal and newborn health receives considerably less funding than reproductive health or child health, which is a persistent issue requiring urgent attention. Funding Bill & Melinda Gates Foundation; Partnership for Maternal, Newborn & Child Health. more

External Link

External Link (216)

National spending on health by source for 184 countries between 2013 and 2040

Dieleman, J.; Templin, T.; Sadat, N. et al. (2016) CC

A general consensus exists that as a country develops economically, health spending per capita rises and the share of that spending that is prepaid through government or private mechanisms also rises. However, the speed and magnitude of these changes vary substantially across countries, even at simi...lar levels of development. In this study, we use past trends and relationships to estimate future health spending, disaggregated by the source of those funds, to identify the financing trajectories that are likely to occur if current policies and trajectories evolve as expected. Methods We extracted data from WHO's Health Spending Observatory and the Institute for Health Metrics and Evaluation's Financing Global Health 2015 report. We converted these data to a common purchasing power-adjusted and inflation-adjusted currency. We used a series of ensemble models and observed empirical norms to estimate future government out-of-pocket private prepaid health spending and development assistance for health. We aggregated each country's estimates to generate total health spending from 2013 to 2040 for 184 countries. We compared these estimates with each other and internationally recognised benchmarks. Findings Global spending on health is expected to increase from US$7·83 trillion in 2013 to $18·28 (uncertainty interval 14·42–22·24) trillion in 2040 (in 2010 purchasing power parity-adjusted dollars). We expect per-capita health spending to increase annually by 2·7% (1·9–3·4) in high-income countries, 3·4% (2·4–4·2) in upper-middle-income countries, 3·0% (2·3–3·6) in lower-middle-income countries, and 2·4% (1·6–3·1) in low-income countries. Given the gaps in current health spending, these rates provide no evidence of increasing parity in health spending. In 1995 and 2015, low-income countries spent $0·03 for every dollar spent in high-income countries, even after adjusting for purchasing power, and the same is projected for 2040. Most importantly, health spending in many low-income countries is expected to remain low. Estimates suggest that, by 2040, only one (3%) of 34 low-income countries and 36 (37%) of 98 middle-income countries will reach the Chatham House goal of 5% of gross domestic product consisting of government health spending. Interpretation Despite remarkable health gains, past health financing trends and relationships suggest that many low-income and lower-middle-income countries will not meet internationally set health spending targets and that spending gaps between low-income and high-income countries are unlikely to narrow unless substantive policy interventions occur. Although gains in health system efficiency can be used to make progress, current trends suggest that meaningful increases in health system resources will require concerted action. Funding Bill & Melinda Gates Foundation. more

Download (24)

View PDF (25)

Tracking AMR Country Self Assessment Survey (TrACSS) 2022 Country Report Namibia

Food and Agriculture Organization of the United Nations FAO; UN environment programme; World Health Organization WHO; et al. (2022) C_WHO

Fact sheet

External Link

External Link (164)

Malaria “chemoprevention and vaccination strategies” for children living in endemic areas of Africa: a review

Nambatya, W.; M. Ocan, B. Robberstad , et al. (2025) CC

Front. Malar. 3:1336324. doi: 10.3389/fmala.2025.1336324

External Link

External Link (94)

Antimalarial drugs for treating and preventing malaria in pregnant and lactating women

Saito, M.; Gilder, M. E.; McGready, R. et al. (2018) C2

EXPERT OPINION ON DRUG SAFETY 2018, VOL. 17, NO. 11, 1129–1144. Malaria during and after pregnancy contributes significantly to maternal mortality and adverse fetal outcomes. While effective and safe antimalarial treatments are essential, quinine — an older, less effective drug — has long bee... more

External Link

External Link (64)

Empfehlungen zur Malariaprophylaxe

Rothe, C.; O. Veit, D. Rosenbusch, et al. Georg Thieme Verlag KG (2024) CC2

Flugmedizin · Tropenmedizin · Reisemedizin - FTR 2024; 31(04): 165-206 DOI: 10.1055/a-2351-8414

External Link

External Link (74)

Preventive malaria treatment among school-aged children in sub-Saharan Africa: a systematic review and meta-analyses

Cohee, LM.; C. Opondo, S. E Clarke, et al. (2020) C1

Lancet Glob Health 2020 Published Online October 22, 2020 https://doi.org/10.1016/S2214-109X(20)30325-9

External Link

External Link (45)

Identification and management of co-infections in people with malaria

Cunnington, A.; A. Abbara, F. Kaduni Bawa, et al. (2024) CC2

BMJ 2024 Mar 13:384:e077512. doi: 10.1136/bmj-2023-077512. Co-infections in individuals with malaria are common, particularly in endemic areas, and can significantly impact disease severity and outcomes. Effective management requires prompt diagnosis of both malaria and any co-occurring infections,... more

External Link

External Link (86)

HIV-1 Impact on Malaria Transmission: A Complex and Relevant Global Health Concern

Roberds, A.; E. Ferraro, S. Luckhart, et al. (2021) CC2

Front. Cell. Infect. Microbiol., 12 April 2021 Sec. Parasite and Host Volume 11 - 2021 | https://doi.org/10.3389/fcimb.2021.656938 Over the past several decades, malaria/HIV-1 co-infection has become a significant global public health problem in co-endemic areas of the world.